[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349294-105":59,"doc-detail-349294-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","beyond-the-primary-site-molecular-insights-and-clinical-implications-of-cancer-metastatic-overlap-between-lung-and-urological-organ-cancers-review","Beyond the primary site - Molecular insights and clinical implications of cancer metastatic overlap between lung and urological organ cancers - Review","","Metastasis between primary lung cancers and urological malignancies, including prostate, renal and bladder cancers, creates diagnostic and therapeutic challenges. Epidemiological evidence indicates frequent bidirectional overlap that worsens patient survival. This review integrates current molecular findings and clinical consequences of metastatic crosstalk, focusing on shared molecular programs such as the C-X-C chemokine receptor 4/C-X-C motif chemokine ligand 12 axis, hepatocyte growth factor/mesenchymal-epithelial transition signaling and epithelial-mesenchymal plasticity. It also examines how organ-specific metastatic niches and immune contexts shape treatment responses. Molecular profiling and liquid biopsies are improving diagnostic precision, supporting mechanism-centered approaches for personalized management in complex clinical settings.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/beyond-the-primary-site-molecular-insights-and-clinical-implications-of-cancer-metastatic-overlap-between-lung-and-urological-organ-cancers-review/349294/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/beyond-the-primary-site-molecular-insights-and-clinical-implications-of-cancer-metastatic-overlap-between-lung-and-urological-organ-cancers-review/349294.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical challenges does metastatic overlap between lung and urological cancers create?","Question",{"text":112,"@type":113},"It complicates both diagnosis and treatment because lung cancers and urological malignancies can metastasize in a bidirectional and frequently overlapping manner. The overlap is associated with worse survival outcomes and distinct prognostic disadvantages.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which shared molecular pathways are highlighted in the review?",{"text":117,"@type":113},"The review emphasizes shared molecular toolkits, including the C-X-C chemokine receptor 4/C-X-C motif chemokine ligand 12 axis, hepatocyte growth factor/mesenchymal-epithelial transition factor signaling, and epithelial-mesenchymal plasticity. These pathways support dissemination and colonization.",{"name":119,"@type":110,"acceptedAnswer":120},"How do metastatic niches and immune contextures influence therapy response?",{"text":121,"@type":113},"The metastatic niche differs across organs in immune composition and cellular architecture, which can alter therapeutic effectiveness. The review explores how these features contribute to variability in treatment responses.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349294,1790388564,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","MOLECULAR MEDICINE REPORTS 34: 214, 2026  \nBeyond the primary site: Molecular insights and clinical implications of cancer metastatic overlap between lung and urological organ cancers (Review)  \nYINHUAN WANG 1 and JIEFANG GUAN2  \n1Department of Urology, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu 730900, P.R. China; 2Department of Thoracic Surgery, The Third Affiliated Hospital of Gansu University of Chinese Medicine, Baiyin, Gansu 730900, P.R. China  \nReceived November 25, 2025; Accepted March 23, 2026  \nDOI: 10. 3892/mmr.2026.13924  \nAbstract. Metastasis between primary lung cancers and urological malignancies, for example prostate, renal and bladder cancers, poses diagnostic and therapeutic chal‑ lenges. Previous epidemiological data underscore a frequent bidirectional overlap that adversely affects patient survival. This review synthesizes current molecular insights and clinical implications of this metastatic crosstalk, delineating how these distinct tumor types exploit shared molecular toolkits, including the C‑X‑C chemokine receptor 4/C‑X‑C motif chemokine ligand 12 axis, hepatocyte growth factor/mesenchymal‑epithelial transition factor signaling and epithelial‑mesenchymal plasticity, to facilitate dissemina‑ tion and colonization. The distinct immune contextures and cellular architectures of the metastatic niche in different organs have also been explored, revealing their notable influ‑ ence on therapeutic responses. Although molecular profiling and liquid biopsies have been refining diagnostic precision and allowing for a shift toward mechanism‑centric agnostic  \nCorrespondence to: Dr Jiefang Guan, Department of Thoracic Surgery, The Third Affiliated Hospital of Gansu University of Chinese Medicine, 222 Silong Road, Baiyin, Gansu 730900, P.R. China  \nE‑mail: [15209435958@163.com](15209435958@163.com)  \nAbbreviations: CAFs, cancer‑associated fibroblasts; CAR‑T, chimeric antigen receptor T‑cell; ctDNA, circulating tumor DNA; dMMR, mismatch‑repair deficient; EMT, epithelial‑mesenchymal transition; FAP, fibroblast activation protein; ICIs, immune‑ checkpoint inhibitors; MDT, multidisciplinary team; MET, mesenchymal‑epithelial transition; MSI‑H, microsatellite instability‑high; NSCLC, non‑small cell lung cancer; PARP, poly(ADP‑ribose) polymerase; PD‑L1, programmed death‑ligand 1; RCC, renal cell carcinoma; TAMs, tumor‑associated macrophages; TLS, tertiary lymphoid structure; TMB, tumor mutational burden; TME, tumor microenvironment  \nKey words: organotropism, metastatic niche, lung cancer, urological cancers, liquid biopsy, TME, targeted therapy  \ntherapies, organ‑specific microenvironments continue to modulate drug efficacy. Integration of these insights is neces‑ sary for advancing personalized management strategies and improving outcomes for patients in this complex clinical setting.  \nContents  \n1. Introduction  \n2. Hallmarks of metastasis: A shared toolkit for dissemination  \n3. Molecular drivers of site‑specific tropism  \n4. Tumor microenvironment (TME) and immune contextureat the metastatic site  \n5. Diagnostic dilemmas and the path to precision  \n6. Therapeutic implications and the era of agnostic oncology  \n7. Future perspectives  \n8. Conclusions  \n1. Introduction  \nMetastatic disease remains the predominant determinant of cancer‑related mortality, and previous population‑based anal‑ yses indicate that bidirectional dissemination of cancer cells between the lungs and urological organs is more frequent than previously appreciated (1). A study by Deng et al (1) reported that, based on data from the Surveillance, Epidemiology and End Results database (SEER) (2), 18.4% of patients with de novo metastatic prostate adenocarcinoma presented with pulmo‑ nary involvement. In this analysis, bone represented the most common metastatic site, whereas pulmonary involvement was associated with a distinct prognostic disadvantage. This subset exhibited a median overall survival (OS) that wa","cbCaisjUsU89Yyfk","https://ap.wps.com/l/cbCaisjUsU89Yyfk","pdf",2489026,16,"English","# Introduction\n## Hallmarks of metastasis: A shared toolkit for dissemination\n## Molecular drivers of site-specific tropism\n## Tumor microenvironment (TME) and immune contexture at the metastatic site\n## Diagnostic dilemmas and the path to precision\n## Therapeutic implications and the era of agnostic oncology\n## Future perspectives\n## Conclusions","[{\"question\":\"What clinical challenges does metastatic overlap between lung and urological cancers create?\",\"answer\":\"It complicates both diagnosis and treatment because lung cancers and urological malignancies can metastasize in a bidirectional and frequently overlapping manner. The overlap is associated with worse survival outcomes and distinct prognostic disadvantages.\"},{\"question\":\"Which shared molecular pathways are highlighted in the review?\",\"answer\":\"The review emphasizes shared molecular toolkits, including the C-X-C chemokine receptor 4/C-X-C motif chemokine ligand 12 axis, hepatocyte growth factor/mesenchymal-epithelial transition factor signaling, and epithelial-mesenchymal plasticity. These pathways support dissemination and colonization.\"},{\"question\":\"How do metastatic niches and immune contextures influence therapy response?\",\"answer\":\"The metastatic niche differs across organs in immune composition and cellular architecture, which can alter therapeutic effectiveness. The review explores how these features contribute to variability in treatment responses.\"}]","Beyond the primary site - Molecular insights and clinical implications of cancer metastatic overlap between lung and urological organ cancers - Review | PDF",1790082623,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd3d4be127f1ecc553952b373576293a.webp",983,1357,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db7ac9d57dbf53131346a0c1819426c6.webp",982,1356,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b69b61f1bb7c95baebf37b2176dd66c2.webp",981,1354,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a39f188b9ca5111dedf885404a301af.webp",980,1353]